Oligonucleotide Synthesis Market Astonishing 10.3% CAGR by Product Type, Key Application, Size on top Key Player Assessment 2019 to 2023

Oligonucleotide Synthesis Market Therapeutic Assessment 2019 by Product Type-synthesized oligonucleotides, reagents and equipment, by Application-diagnostic, genetic testing, research, therapeutics, gene synthesis, by End User-academic research institutes, diagnostic laboratories, pharmaceutical - Forecast till 2022

Pune, India - March 14, 2019 /MarketersMedia/ —

Oligonucleotide Synthesis Market Overview

The global oligonucleotide synthesis market is expecting an astonishing 10.3% CAGR during the forecast period (2014-2022), reveals Market Research Future (MRFR) in a broadly demonstrated report. The report further incorporates factors that are contributing much for the market growth which includes ventures and investments made by big pharmaceutical companies, contract manufacturing organization’s involvement in the market and global prevalence of chronic diseases spurring the demand for better medicines.

Advancing technologies have substantially raised the hope for better treatment in the healthcare sector. One of the chief driving forces is biotechnology which is constantly updating itself and impacting the former sector. Of the many ensuing projects, oligonucleotide synthesis is an evolving technique that forms inexpensive, custom-made oligonucleotides with the desired sequence. Its importance lies in its contribution in DNA or RNA synthesizing and hybridization and in the synthesis of artificial genes.

Get Free sample Copy at https://www.marketresearchfuture.com/sample_request/2337

However, the cost can prove to be a great market deterrent. The oligonucleotide synthesis requires expert hands, and its research and development process can incur high expenditure which can impede the growth in the near future. But it has the potential to counter chronic diseases by developing suitable drugs which can create a favorable ambiance for the market.

Segmentation:

The global oligonucleotide synthesis market can be segmented by product type, application, and end-users.

Based on product type, the market can be segmented into synthesized oligonucleotides, reagents and equipment.

Application-wise segmentation of the market includes diagnostic, genetic testing, research, therapeutics, gene synthesis, library preparation, drug target screening, and others.

Based on end-users, the market comprises academic research institutes, diagnostic laboratories, and pharmaceutical & biotechnology companies.

Regional Analysis:

Region-specific segmentation of the market includes North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America has the largest market for oligonucleotide synthesis. The region invests in research and development substantially, and it has a superlative infrastructure in biotechnology sector which is triggering further market growth. In addition, the healthcare sector, with an eye searching constantly for new treatments for chronic diseases such as cancer and diabetes, is taking the market forward. Governments and private investors are also funding researches as they are equally eager to get positive results.

Europe is also fetching in substantial revenue as the region has almost similar kind of ambiance like North America for advanced researches. And its position has further been solidified by the presence of big league market players. The APAC region is showing lots of promises as emerging economies such as India and China are investing heavily in biotechnological researches and developments which is directly expanding the scope for oligonucleotide synthesis market growth. Governments in this region are also supporting the market considerably by approving funds.

Brows Complete Premium Research at https://www.marketresearchfuture.com/reports/oligonucleotide-synthesis-market-2337

Market Dashboard:

The competitive market is witnessing several strategies being implemented by market behemoths. For instance, Danaher’s taking over of Integrated DNA Technologies can be seen as an effort to enhance the market portfolio. LGC is following the same suit by acquiring BioAutomation Corporation, the latter a manufacturer of the renowned MerMade oligo synthesis instruments. On the other hand, STA Pharmaceuticals has signed a collaboration with Regulus to establish high-quality oligonucleotide research and development center.

Some of the key players in this market are Integrated DNA Technologies, Inc (U.S), GE Healthcare (U.S.), Agilent Technologies Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Bioautomation Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), L.G.C Biosearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), and Nitto Denko Avecia Inc. (Japan) and others.

TABLE OF CONTENTS

1... Report Prologue

2... Market Introduction

3... Research Methodology

4... Market Dynamics

5... Market Factor Analysis

5.1 Value/Supply Chain Analysis

5.2 Porter's 5 Forces Analysis

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

6... Global Oligonucleotide Pool Library Market, By Types (USD Million)

6.1 Introduction

6.2 Historical Market Growth

6.3 Y-O-Y Growth Projections By Types

6.4 Market Size By Types

6.4.1 DNA Pool

6.4.2 RNA Pool

Ask for any Query at https://www.marketresearchfuture.com/enquiry/2337

7... Global Oligonucleotide Pool Library Market, By Methods (USD Million)

7.1 Introduction

7.2 Historical Market Growth

… Continued

Contact Info:
Name: Mr. Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar, Pune
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/oligonucleotide-synthesis-market-2337

Source URL: https://marketersmedia.com/oligonucleotide-synthesis-market-astonishing-103-cagr-by-product-type-key-application-size-on-top-key-player-assessment-2019-to-2023/492506

Source: MarketersMedia

Release ID: 492506

More News From digitalpressnetwork.com

Small blast in French city of Lyon wounds 7; cause unclear

May 24, 2019

LYON, France — An explosion Friday on a busy pedestrian street in the French city of Lyon injured seven people, local officials said. The cause of the blast that occurred in or outside a branch of the bakery chain Brioche Doree wasn't immediately clear, according to Kamel Amerouche, the regional authority's communications chief. Authorities couldn't confirm French media reports that a small package had exploded. The victims sustained leg injuries that weren't life-threatening, Amerouche told The Associated Press. Live television images showed the Brioche Doree sign intact and police vans and an ambulance on the street, which had been cordoned...

Missouri governor signs bill banning abortions at 8 weeks

May 24, 2019

JEFFERSON CITY, Mo. — Missouri Gov. Mike Parson on Friday signed a bill that bans abortions on or beyond the eighth week of pregnancy without exceptions for cases of rape or incest, making it among the most restrictive abortion policies in the nation. Under the law that comes into force Aug. 28, doctors who violate the eight-week cutoff could face five to 15 years in prison. Women who terminate their pregnancies cannot be prosecuted. A legal challenge is expected, although it's unclear when that might occur. The measure includes exceptions for medical emergencies, such as when there is a risk...

GOP conservative temporarily blocks $19B disaster bill

May 24, 2019

WASHINGTON — A House GOP conservative complaining of Washington's free-spending and opaque ways blocked a long-overdue $19 billion disaster aid bill on Friday, extending a tempest over hurricane and flood relief that has left the measure meandering for months. Texas Republican Chip Roy, a former aide to Texas firebrand Sen. Ted Cruz, objected to speeding the measure through a nearly empty chamber, also complaining that it does not contain any of President Donald trump's $4.5 billion request for dealing with a migrant refugee crisis on the U.S.-Mexico border. "It is a bill that that includes nothing to address the international...

CEOs get $800,000 pay raise, leaving workers further behind

May 24, 2019

NEW YORK — Did you get a 7% raise last year? Congratulations, yours was in line with what CEOs at the biggest companies got. But for chief executives, that 7% was roughly $800,000. Pay for CEOs at S&P 500 companies rose to a median of $12 million last year, including salary, stock and other compensation, according to data analyzed by Equilar for The Associated Press. The eight-figure packages continue to rise as companies tie more of their CEOs' pay to their stock prices, which are still near record levels, and as profits hit an all-time high last year due to...

US stocks rebound, but still face losses for the week

May 24, 2019

NEW YORK — U.S. stocks rebounded in morning trading on Wall Street Friday, but were still on track for a third straight week of losses. The market has been swaying between gains and losses all week as investors face the prospect that the trade war between the U.S. and China will drag on longer than anticipated. Trading has been volatile since the dispute escalated earlier this month, with both sides taking measures to raise tariffs on each other's goods. President Donald Trump said Thursday that he expects to meet with his Chinese counterpart Xi Jinping at a summit next month...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH